信迪利单抗联合安罗替尼治疗 PD-L1 阳性 肺肉瘤样癌 1 例并文献复习.

This article reports on a 78-year-old male patient with advanced pulmonary sarcomatoid carcinoma with positive PD-L1 expression, who achieved partial remission (PR) and progression-free survival (PFS) of 30 months with sindilizumab and amilorotinib. Grade 2 hypertension and other transient cardiac problems occurred during treatment, but overall quality of life was good. [ABSTRACT FROM AUTHOR]